View in EDS

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: An 18-week, randomized, open-label study

Saved in:
Bibliographic Details
Title: Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: An 18-week, randomized, open-label study
Authors: Raz, Itamar1 ntv502@netvision.net.il, Stranks, Stephen2, Filipczak, Robert3, Joshi, Pankaj4, Lertoft, Benedikte5, Rastam, Jacob5, Chow, Chun-Chung6, Shaban, Joseph7
Source: Clinical Therapeutics. Sep2005, Vol. 27 Issue 9, p1432-1443. 12p.
Database: Academic Search Ultimate
Description
ISSN:01492918
DOI:10.1016/j.clinthera.2005.09.001